Study results showed a high rate of loss to follow-up in patients with neovascular age-related macular degeneration treated with anti-VEGF injections in the U.S., with nearly 1 in 5 patients lost to follow-up.
“Because retina clinics are often overwhelmed by patients requiring intravitreal injections, it’s easy to overlook patients who do not regularly follow-up and eventually are lost to follow-up,” Rahul N. Khurana, MD, vitreoretinal surgeon with of Northern California Retina Vitreous Associates Medical Group Inc., said during his presentation at the virtual American
Uncategorized